InDex Pharmaceuticals announces successful interactions with the PMDA for the clinical development of cobitolimod in Japan ...Middle East

PR Newswire - News
STOCKHOLM, Aug. 16, 2022 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company has received positive feedback from the Japanese regulatory authority, the Pharmaceuticals and Medical Devices Agency (PMDA), regarding the clinical development plan for a...

Hence then, the article about index pharmaceuticals announces successful interactions with the pmda for the clinical development of cobitolimod in japan was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( InDex Pharmaceuticals announces successful interactions with the PMDA for the clinical development of cobitolimod in Japan )

Apple Storegoogle play

Last updated :

Also on site :